← back to search

Baixue Lv

Union Hospital ·
Area of research
Genetics · Molecular Biology
Research interest
Research interests include RNA, Nucleic acid, Chemistry, Alu element, Medicine, and Retinitis pigmentosa.
h-index
—
citations
20
works
4
NIH funding
—
primary concept
—
email
✉ Find email ↗

Recent publications

Molecular Mechanisms of Alu and LINE-1 Interspersed Repetitive Sequences Reveal Diseases of Visual System Dysfunction
Ocular Immunology and Inflammation 2022cited by 8position: middledoi
Anti-aging and anti-oxidant activities of murine short interspersed nuclear element antisense RNA
European Journal of Pharmacology 2021cited by 7position: middledoi
The preparation of endotoxin-free genetically engineered murine B1 antisense RNA
Analytical Biochemistry 2020cited by 5position: middledoi
Preparation of genetically engineered murine SINE RNA without endotoxin contamination
MethodsX 2020cited by 0position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Suleman Shah · Shenzhen University4 papers (2020–2022)Zhanjun Lv · Hebei Medical University4 papers (2020–2022)Zhixue Song · Hebei Medical University4 papers (2020–2022)Murad Khan · Birmingham and Midland Eye Centre4 papers (2020–2022)Ning Ji · Chinese Academy of Medical Sciences & Peking Union Medical College3 papers (2020–2021)Lifang Yan · Mississippi State University3 papers (2020–2021)Peiyuan Wu · Chinese Academy of Sciences2 papers (2021–2022)Xiufang Wang · Hebei Medical University2 papers (2020–2022)Libo Su · Tianjin Medical University2 papers (2020–2021)Xiufang Wang · Huazhong University of Science and Technology2 papers (2020–2021)Arshad Mehmood · Combined Military Hospital1 papers (2022–2022)Xin Liu · Nanjing University of Chinese Medicine1 papers (2020–2020)Shufeng Liu · Yantai University1 papers (2021–2021)Xin Liu · Shenyang Aerospace University1 papers (2020–2020)Xin Liu · Shenyang Agricultural University1 papers (2021–2021)Ning Ji · Shanghai University1 papers (2022–2022)Zheng Long · Hebei Medical University1 papers (2021–2021)